The National Pharmacy Association stated the shortages pose a "serious risk to patient safety," citing supply-chain volatility from the Middle East conflict alongside ingredient scarcity, manufacturing disruption, the UK's smaller medicines budget relative to other EU countries, and changing HRT prescribing habits. The call for reader testimony follows the June 18 report that shortages are the worst on record.
The call for reader testimony follows the June 18 report that shortages are the worst on record.